<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03225313</url>
  </required_header>
  <id_info>
    <org_study_id>722014</org_study_id>
    <nct_id>NCT03225313</nct_id>
  </id_info>
  <brief_title>Comparison Between Ultra Sound Guided Rectus Sheath Block and Field Block for Midline Hernia Repair</brief_title>
  <official_title>Ultra Sound Guided Rectus Sheath Block or Field Block for Midline Hernia Repair: A Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Theodor Bilharz Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Theodor Bilharz Research Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective randomized double blinded controlled clinical trial will be done with a total
      number of 75 patients will be divided into 3 groups. To compare between Ultra-sound guided
      rectus sheath block VS Field block infiltration in providing a good analgesia for patients
      undergoing midline hernia repair to detect which one is superior.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 20, 2017</start_date>
  <completion_date type="Actual">December 20, 2017</completion_date>
  <primary_completion_date type="Actual">October 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Immediate Postoperative Pain</measure>
    <time_frame>evaluation of postoperative pain in patients immediately after the procedure.</time_frame>
    <description>Evaluation of the intensity of postoperative pain using Visual Analogue score for pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain at 2 hours after procedure.</measure>
    <time_frame>evaluation of postoperative pain in patients at 2 hours after procedure.</time_frame>
    <description>Evaluation of the intensity of postoperative pain at 2 hours after procedure using Visual Analogue score for pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain at 6 hours after procedure.</measure>
    <time_frame>Evaluation of postoperative pain in patients at 6 hours after procedure.</time_frame>
    <description>Evaluation of postoperative pain at 6 hours after procedure using Visual Analogue score for pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the level of serum cortisol &amp; catecholamine</measure>
    <time_frame>Measurement of serum cortisol and catecholamine level 30 minutes before induction of anesthesia , 1 hour after beginning of surgery, 2 and 6 hours after the end of surgery.</time_frame>
    <description>Measurement of cortisol and catecholamine level in blood (nanogram per milliliter) using the ELISA technique</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Rectus Sheath Block</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline will be injected in the rectus sheath</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rectus block group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bupivicaine will be injected in the rectus sheath</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bupivicaine will be injected locally</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hydrochloride</intervention_name>
    <description>ultra sound guided injection into the rectus sheath</description>
    <arm_group_label>Rectus block group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>injected into rectus sheath &amp; locally</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hydrochloride</intervention_name>
    <description>injected locally</description>
    <arm_group_label>Local group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Elective midline hernia repair surgery.

          2. Age: adult patients between 18 - 60 years old.

          3. Gender: Both male and female.

          4. ASA Class: I &amp; II.

        Exclusion Criteria:

          1. Refusal of patient.

          2. Pregnancy and lactation.

          3. Fever or sepsis.

          4. Patients ASA III or IV.

          5. Addicts and drug abusers.

          6. Patients taking corticosteroids or any cardio - active drugs.

          7. Local infection at site of the injection.

          8. Allergy to any of the study medications.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Theodor Bilharz Research Institute</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2017</study_first_submitted>
  <study_first_submitted_qc>July 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2017</study_first_posted>
  <last_update_submitted>April 2, 2018</last_update_submitted>
  <last_update_submitted_qc>April 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Theodor Bilharz Research Institute</investigator_affiliation>
    <investigator_full_name>Mohamed Hussein</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia and Surgical intensive care</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

